Syncope and Transient Loss of Consciousness : MULTIDISCIPLINARY MANAGEMENT -- Contents -- Contributors -- Preface -- Part 1 Syncope and TLOC overview -- 1 Definition and classification of syncope and transient loss of consciousness -- 2 Epidemiologic aspects of transient loss of consciousness/syncope -- 3 Pathophysiology of syncope: postural,neurally-mediated, and arrhythmic -- 4 Cerebral perfusion in syncope -- 5 Risk stratification-impact on diagnostic strategy -- Part 2 Clinical evaluation strategies -- 6 Value and limitations of clinical history in assessing cause of syncope -- 7 Emergency department evaluation of transient loss of consciousness/ syncope -- 8 The essential autonomic assessment for evaluating the cause of syncope -- 9 Neurally-mediated reflex syncope: recognition by history and clinical testing -- 10 Value and limitations of ambulatory electrocardiographic monitoring -- 11 Recording ambulatory blood pressure in the syncope and TLOC evaluation -- 12 Electrophysiologic testing: value and limitations in the transient loss of consciousness/syncope evaluation -- 13 Intolerance to upright posture in autonomic failure and the postural tachycardia syndrome: assessment and treatment strategies -- 14 Improving tolerance to upright posture: current status of tilt-training and other physical maneuvers -- 15 Syncope in patients with bundle-branch block and other conduction system abnormalities -- Part 3 Specific conditions -- 16 Treatment strategies in neurally-mediated reflex syncope: effectiveness of drugs, pacing, and physical maneuvers -- 17 Structural heart disease, syncope, and risk of sudden death: selection of patients for implantable cardioverter-defibrillator therapy -- 18 Channelopathies as a cause of syncope -- 19 Distinguishing seizures and pseudosyncope from syncope.

20 Syncope and transient loss of consciousness in children and adolescents: congenital and acquired conditions -- 21 Transient loss of consciousness, syncope, and falls in the elderly -- 22 Drug-induced (iatrogenic) syncope -- Part 4 Economic and research aspects -- 23 Syncope and the competitive athlete: recommendations for evaluation and permission to compete -- 24 Role of syncope management units -- 25 The impact of syncope and transient loss of consciousness on quality of life -- Part 5 Current controversies and future directions -- 26 Driving and flying restrictions for the syncope and/or implanted cardiac device patient -- 27 Clinical trials landscape: what's new, what's ongoing, what do we need -- 28 Syncope and transient loss of consciousness: multidisciplinary management -- 29 Syncope practice guidelines initiative -- Appendix: syncope consortium members -- Index.